Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06522256 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial

Study acronym: HPVsign
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 6, 2025 to Mar 20, 2025
    • Site details revised at 3 of 3 sites
    v5
  2. Start date: Nov 1, 2024 to Feb 6, 2025
    • Site contacts updated at 3 of 3 sites
    v4
  3. Start date: Sep 15, 2024 to Nov 1, 2024
    • Primary and study completion dates: Jun 30, 2027 to Jul 30, 2027
    • Site contacts updated at 3 of 3 sites
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
HPVsign is a cross-sectional, non-comparative, multicenter study involving all participants included in the HPV substudy of the ANRS IPERGAY trial. The study proposes to evaluate the cumulative incidence of high-grade lesions and/or anal cancers using high-resolution anoscopy (HRA) during the HPVsign study and/or diagnosed since the end of participation in the ANRS IPERGAY trial.
Trial Details
NCT Number NCT06522256
Lead Sponsor ANRS, Emerging Infectious Diseases
Collaborators: INSERM SC10-US19
Conditions
(from sponsor)		 HPV Infection, Anal Cancer
Related terms Anus Neoplasms, Papillomavirus Infections
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov